Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced that on October 28, 2025, it entered into a definitive ...

Q3 2025 Earnings Call Transcript October 28, 2025 Wayfair Inc. misses on earnings expectations. Reported EPS is $-0.76154 EPS ...

Semiconductor stocks power the AI era, tested by trade tensions and rich valuations. NVIDIA leads, while STMicroelectronics eyes recovery.

Advantage Energy Ltd. ("Advantage" or the "Corporation") is pleased to report 2025 third quarter financial and operating results. 2025 Third ...

Q3 2025 Earnings Call October 28, 2025 9:00 AM EDTCompany ParticipantsGregory Ketron - Head of Investor Relations ...

TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has completed in the randomized cohort of the Phase 3 ENHANCE trial evaluating a consolidated ...

BRIUMVI is currently approved in the United States, as well as several countries outside of the U.S., as a one-hour intravenous (IV) infusion administered twice a year, following the starting dose, in ...